Boosting of ALVAC-SIV Vaccine-Primed Macaques with the CD4-SIVgp120 Fusion Protein Elicits Antibodies to V2 Associated with a Decreased Risk of SIV(mac251) Acquisition

The recombinant ALVAC vaccine coupled with the monomeric gp120/alum protein have decreased the risk of HIV and SIV acquisition. Ab responses to the V1/V2 regions have correlated with a decreased risk of virus acquisition in both humans and macaques. We hypothesized that the breadth and functional pr...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:J Immunol
Huvudupphovsmän: Gordon, Shari N., Liyanage, Namal P. M., Doster, Melvin N., Vaccari, Monica, Vargas-Inchaustegui, Diego A., Pegu, Poonam, Schifanella, Luca, Shen, Xiaoying, Tomaras, Georgia D., Rao, Mangala, Billings, Erik A., Schwartz, Jennifer, Prado, Ilia, Bobb, Kathryn, Zhang, Wenlei, Montefiori, David C., Foulds, Kathryn E., Ferrari, Guido, Robert-Guroff, Marjorie, Roederer, Mario, Phan, Tran B., Forthal, Donald N., Stablein, Donald M., Phogat, Sanjay, Venzon, David J., Fouts, Timothy, Franchini, Genoveffa
Materialtyp: Artigo
Språk:Inglês
Publicerad: AAI 2016
Ämnen:
Immunotherapy and Vaccines
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5026031/
https://ncbi.nlm.nih.gov/pubmed/27591322
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4049/jimmunol.1600674
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk